Folate reduces stroke-related risksFolate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
We explored the effects of folic acid and homocysteine levels on the outcomes of ischemic stroke in over 3,500 patients. Our findings revealed that higher folate levels were linked to a 29% lower risk of severe complications, such as death or major disability, within three months after a stroke.
In contrast, elevated homocysteine levels significantly increased the risk, suggesting that homocysteine may mediate some benefits of folate. Overall, maintaining high folate levels may play a protective role following ischemic stroke.
Read More
Folic acid reduces stroke riskEffect of plateletcrit and methylenetetrahydrofolate reductase (MTHFR) C677T genotypes on folic acid efficacy in stroke prevention.
We explored how platelet activation measures and specific genetic factors might shape the effectiveness of folic acid in preventing strokes. Our analysis, based on data from the China Stroke Primary Prevention Trial with over 11,000 hypertensive adults, revealed that individuals with low plateletcrit and certain MTHFR genotypes experienced significant benefits from folic acid treatment. Specifically, this group saw a striking 66% reduction in stroke risk. Thus, identifying low plateletcrit could help target folic acid treatment to those at highest risk.
Read More
Stroke linked to homocysteine levelsHyperhomocysteinemia Presenting as Stroke in a Young Individual: A Case Report.
We examined a case involving a young man in his late 20s who suffered a sudden ischemic stroke. This incident was surprisingly linked to elevated homocysteine levels, a risk factor often associated with stroke. Through our observations, it became clear that hyperhomocysteinemia is an important factor to consider, even among younger adults who might otherwise seem healthy.
Following the stroke, the patient received targeted treatment along with a regimen that included folic acid, vitamin B6, vitamin B12, and methylcobalamin. As a result, we saw significant improvement in his condition, culminating in his discharge with normalized homocysteine levels.
Highlighting this case is particularly important in regions like Pakistan, where hyperhomocysteinemia is notably prevalent. Our experience emphasizes the need for healthcare providers to thoroughly evaluate potential stroke causes, including the role of homocysteine, especially in younger populations.
Read More
Vitamin B12 alleviates stroke effectsFunctional regulation of microglia by vitamin B12 alleviates ischemic stroke-induced neuroinflammation in mice.
We investigated how vitamin B12 impacts neuroinflammation and recovery after an ischemic stroke. Our findings revealed that vitamin B12 plays a crucial role in programming microglial cells—immune cells in the brain—helping them divide and activate effectively, which is vital during the healing process. This treatment appeared to improve the metabolism of these cells as well, promoting better functionality and reduced brain injury after a stroke.
Interestingly, we found that vitamin B12 significantly limited gene alterations associated with strokes in these microglia. Throughout the acute phase of an ischemic stroke, vitamin B12 altered the activities of different microglial subsets, leading to less brain damage and enhanced neurological recovery for the mice in our study. However, when we depleted microglia before administering the stroke, the beneficial effects of vitamin B12 disappeared, highlighting the importance of microglia in this process.
Overall, our research underscores the potential of vitamin B12 in mitigating neuroinflammation and aiding recovery for stroke victims. Through our preclinical studies, we've established that vitamin B12 may indeed offer a promising avenue for improving neurological outcomes post-stroke, meriting further exploration.
Read More
Folate impacts long-term stroke riskAssociation Between Serum Folate Concentrations and 10-Year Stroke Risk in a Prospective Community Cohort: Mediation and Interaction Analyses.
We investigated the link between serum folate levels and stroke risk over ten years in a community-based study of nearly 5,000 participants.
Our findings revealed that those in the highest folate group had a lower risk for strokes compared to those with minimal folate. Specifically, elevated folate resulted in a significant reduction in hazard ratio for strokes and ischemic strokes.
Interestingly, homocysteine levels appeared to play a substantial role in this relationship, while certain genetic factors influenced the association as well. Overall, inadequate folate concentrations were tied to increased stroke risk.
Read More